Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Folivane is a brand of prescription-only prenatal and nutritional multivitamin/mineral supplements developed by Trigen Laboratories. The product line, which includes variants such as Folivane-F, Folivane-OB, and Folivane-Plus, is formulated to improve the nutritional status of patients, particularly women in the prenatal and postnatal periods, who are experiencing or are at risk for iron and/or folate deficiency anemia. The supplements typically contain a combination of essential nutrients, including iron (as ferrous fumarate and polysaccharide iron complex), folic acid (vitamin B9), vitamin C (ascorbic acid), and various B-complex vitamins and minerals, which work synergistically to support red blood cell production, oxygen transport, and overall metabolic health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Folivane.